OMEROS CORP Investment Income, Net
OMEROS CORP (OMER) reported Investment Income, Net of $1.44 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-01.
Discontinued › Income Statement › Other Income
us-gaap:InvestmentIncomeNet · last filed 2018-03-01
- OMEROS CORP investment income, net for the quarter ending 2014-12-31 was -$205.00K, a 135.59% decline year-over-year.
- OMEROS CORP investment income, net for the quarter ending 2014-09-30 was $3.00K, a 50.00% increase year-over-year.
- OMEROS CORP investment income, net for the quarter ending 2014-06-30 was $5.00K, a 150.00% increase year-over-year.
- OMEROS CORP investment income, net for the quarter ending 2014-03-31 was $2.00K, a 66.67% decline year-over-year.
- OMEROS CORP investment income, net for fiscal 2017 was $1.44M, a 52.80% increase from fiscal 2016.
- OMEROS CORP investment income, net for fiscal 2016 was $945.00K, a 8.25% decline from fiscal 2015.
- OMEROS CORP investment income, net for fiscal 2015 was $1.03M.
- OMEROS CORP investment income, net for fiscal 2014 was -$195.00K, a 133.28% decline from fiscal 2013.
| Period end | Investment Income, Net 3 month | Investment Income, Net 6 month | Investment Income, Net 9 month | Investment Income, Net 12 month | Investment Income, Net 12 month as first filed | Investment Income, Net 204 month | Investment Income, Net 207 month |
|---|---|---|---|---|---|---|---|
| 2017-12-31 | $1.44M 10-K · filed 2018-03-01 | ||||||
| 2016-12-31 | $945.00K 10-K · filed 2018-03-01 | ||||||
| 2015-12-31 | $1.03M 10-K · filed 2018-03-01 | ||||||
| 2014-12-31 | -$205.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | -$202.00K derived: sum of 2 quarters · filed 2017-03-16 | -$197.00K derived: sum of 3 quarters · filed 2017-03-16 | -$195.00K 10-K · filed 2017-03-16 | $12.00K 10-K · filed 2015-03-16 | ||
| 2014-09-30 | $3.00K 10-Q · filed 2014-11-10 | $8.00K derived: sum of 2 quarters · filed 2014-11-10 | $10.00K 10-Q · filed 2014-11-10 | $586.00K derived: sum of 4 quarters · filed 2016-03-15 | |||
| 2014-06-30 | $5.00K 10-Q · filed 2014-08-11 | $7.00K 10-Q · filed 2014-08-11 | $583.00K derived: sum of 3 quarters · filed 2016-03-15 | $585.00K derived: sum of 4 quarters · filed 2016-03-15 | |||
| 2014-03-31 | $2.00K 10-Q · filed 2014-05-12 | $578.00K derived: sum of 2 quarters · filed 2016-03-15 | $580.00K derived: sum of 3 quarters · filed 2016-03-15 | $582.00K derived: sum of 4 quarters · filed 2016-03-15 | |||
| 2013-12-31 | $576.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | $578.00K derived: sum of 2 quarters · filed 2016-03-15 | $580.00K derived: sum of 3 quarters · filed 2016-03-15 | $586.00K 10-K · filed 2016-03-15 | $12.00K 10-K · filed 2014-03-13 | ||
| 2013-09-30 | $2.00K 10-Q · filed 2014-11-10 | $4.00K derived: sum of 2 quarters · filed 2014-11-10 | $10.00K 10-Q · filed 2014-11-10 | $18.00K derived: sum of 4 quarters · filed 2015-03-16 | |||
| 2013-06-30 | $2.00K 10-Q · filed 2014-08-11 | $8.00K 10-Q · filed 2014-08-11 | $16.00K derived: sum of 3 quarters · filed 2015-03-16 | $30.00K derived: sum of 4 quarters · filed 2015-03-16 | |||
| 2013-03-31 | $6.00K 10-Q · filed 2014-05-12 | $14.00K derived: sum of 2 quarters · filed 2015-03-16 | $28.00K derived: sum of 3 quarters · filed 2015-03-16 | $34.00K derived: sum of 4 quarters · filed 2015-03-16 | |||
| 2012-12-31 | $8.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | $22.00K derived: sum of 2 quarters · filed 2015-03-16 | $28.00K derived: sum of 3 quarters · filed 2015-03-16 | $40.00K 10-K · filed 2015-03-16 | |||
| 2012-09-30 | $14.00K 10-Q · filed 2013-11-07 | $20.00K derived: sum of 2 quarters · filed 2013-11-07 | $32.00K 10-Q · filed 2013-11-07 | $43.00K derived: sum of 4 quarters · filed 2014-03-13 | |||
| 2012-06-30 | $6.00K 10-Q · filed 2013-08-09 | $18.00K 10-Q · filed 2013-08-09 | $29.00K derived: sum of 3 quarters · filed 2014-03-13 | $38.00K derived: sum of 4 quarters · filed 2014-03-13 | |||
| 2012-03-31 | $12.00K 10-Q · filed 2013-05-09 | $23.00K derived: sum of 2 quarters · filed 2014-03-13 | $32.00K derived: sum of 3 quarters · filed 2014-03-13 | $46.00K derived: sum of 4 quarters · filed 2014-03-13 | |||
| 2011-12-31 | $11.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-13 | $20.00K derived: sum of 2 quarters · filed 2014-03-13 | $34.00K derived: sum of 3 quarters · filed 2014-03-13 | $51.00K 10-K · filed 2014-03-13 | |||
| 2011-09-30 | $9.00K 10-Q · filed 2012-11-09 | $23.00K derived: sum of 2 quarters · filed 2012-11-09 | $40.00K 10-Q · filed 2012-11-09 | $61.00K derived: sum of 4 quarters · filed 2013-03-18 | $5.58M 10-Q · filed 2011-11-08 | ||
| 2011-06-30 | $14.00K 10-Q · filed 2012-08-07 | $31.00K 10-Q · filed 2012-08-07 | $52.00K derived: sum of 3 quarters · filed 2013-03-18 | $160.00K derived: sum of 4 quarters · filed 2013-03-18 | $5.58M 10-Q · filed 2011-08-09 | ||
| 2011-03-31 | $17.00K 10-Q · filed 2012-05-10 | $38.00K derived: sum of 2 quarters · filed 2013-03-18 | $146.00K derived: sum of 3 quarters · filed 2013-03-18 | $167.00K derived: sum of 4 quarters · filed 2013-03-18 | |||
| 2010-12-31 | $21.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $129.00K derived: sum of 2 quarters · filed 2013-03-18 | $150.00K derived: sum of 3 quarters · filed 2013-03-18 | $167.00K 10-K · filed 2013-03-18 | |||
| 2010-09-30 | $108.00K 10-Q · filed 2011-11-08 | $129.00K derived: sum of 2 quarters · filed 2011-11-08 | $146.00K 10-Q · filed 2011-11-08 | ||||
| 2010-06-30 | $21.00K 10-Q · filed 2011-08-09 | $38.00K 10-Q · filed 2011-08-09 | |||||
| 2009-12-31 | $214.00K 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |